Trials / Completed
CompletedNCT00959634
Pharmacokinetic Study of ABT-126 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This is a study to investigate the process by which ABT-126 is absorbed, distributed, metabolized and eliminated by the body of a healthy volunteer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABT-126 | Dose administered twice daily on Study Days 1-10 |
| DRUG | Placebo | Dose administered twice daily on Study Days 1-10 |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-09-01
- First posted
- 2009-08-14
- Last updated
- 2010-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00959634. Inclusion in this directory is not an endorsement.